Pregled bibliografske jedinice broj: 490386
Thrombolysis for acute ischemic stroke : our experiences as a part of SITS-MOST
Thrombolysis for acute ischemic stroke : our experiences as a part of SITS-MOST // The 50th International Neuropsychiatric Pula Congress : abstracts ; u: Acta Clinica Croatica 49 (2010) (S2)
Pula, Hrvatska, 2010. str. 103-103 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 490386 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Thrombolysis for acute ischemic stroke : our experiences as a part of SITS-MOST
Autori
Roje Bedeković, Marina ; Čorić, Lejla ; Vargek Solter, Vesna ; Breitenfeld, Tomislav ; Supanc, Višnja ; Demarin, Vida
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
The 50th International Neuropsychiatric Pula Congress : abstracts ; u: Acta Clinica Croatica 49 (2010) (S2)
/ - , 2010, 103-103
Skup
International Neuropsychiatric Pula Congress (50 ; 2010)
Mjesto i datum
Pula, Hrvatska, 16.06.2010. - 19.06.2010
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
stroke; thrombolysis
Sažetak
Th rombolysis with intravenous recombinant tissue plasminogen activator (rt-PA) is the fi rst evidence based treatment for acute ischemic stroke which aims to reduce the cerebrovascular lesion. In University Department of Neurology, Sestre milosrdnice University Hospital, Zagreb, thrombolytic therapy with intravenous rtPA (alteplase) in acute ischemic stroke was introduced in 2004. We intend to present our results as refered to demographic, time logistics and clinical outcome data as a part of SITS-MOST (Safe Implementation of Th rombolysis in Stroke - Monitoring Study) in order to compare our results with the results from other centers in Croatia and all other participating centers. Up to now in our center 56 patients (61% males and 39% females, average age 67 years) have been treated with intravenous rt-PA (0, 9 mg/ kg body weight, maximum 90 mg), with 10 % of the dose given as a bolus followed by a 60-minute infusion. Our experiences with thrombolytic therapy with intravenous rt-PA (alteplase) in acute ischemic stroke confi rm the safety and the effi casy of the therapy.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
134-1340036-0033 - Uloga genetskih markera u razvoju cerebralne aterosklerotske bolesti (Demarin, Vida, MZOS ) ( CroRIS)
134-1340036-0034 - Funkcijska dijagnostika moždane cirkulacije (Lovrenčić-Huzjan, Arijana, MZOS ) ( CroRIS)
134-1340036-0035 - Uloga vaskularnih čimbenika rizika u patogenezi Alzheimerove bolesti (Trkanjec, Zlatko, MZOS ) ( CroRIS)
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Višnja Supanc
(autor)
Marina Roje Bedeković
(autor)
Vida Demarin
(autor)
Vesna Vargek-Solter
(autor)
Tomislav Breitenfeld
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus